- Home
- WAFU vs ACXP Comparison
WAFU vs ACXP Comparison
Compare WAFU & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WAFU | ACXP |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 3.8M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WAFU | ACXP |
|---|---|---|
| Price | $1.70 | $1.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $143.67 |
| AVG Volume (30 Days) | 7.2K | ★ 47.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $0.29 |
| 52 Week High | $2.19 | $8.34 |
Technical Indicators
Market Signals| Indicator | WAFU | ACXP |
|---|---|---|
| Relative Strength Index (RSI) | 50.98 | 24.66 |
| Support Level | $1.61 | $0.30 |
| Resistance Level | $1.74 | $2.89 |
| Average True Range (ATR) | 0.04 | 0.17 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 61.54 | 11.03 |
Price Performance
Historical ComparisonAbout WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.